Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView Company states Integrated Drug Discovery services span "multiple therapeutic areas including but not limited to oncologyCNSmetabolic disorderspain & inflammation". Programme counts stated on the same page: Oncology 30+
SCALE 00 studies
Open to sponsorsGeneral clinicalView Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 130 studies
Open to sponsorsGeneral clinicalView